MedicaidCoverageMedium impact
KMAP BULLETIN: Coverage of mRNA RSV Vaccine mResvia
Kansas Medicaid (KanCare)·KS · Family Medicine, Internal Medicine, Geriatrics +1 more·Medical Policy
Effective date
Jun 26, 2024
We identified it
Jun 21, 2026
Summary
Kansas Medicaid now covers the mRNA RSV vaccine mResvia (CPT 90683) for adults 60+ years old, reimbursing at $290.00. This coverage is retroactive to June 26, 2024, and follows ACIP recommendations for vaccination of high-risk patients.
Action Required
Immediately: Billing team should verify Kansas Medicaid coverage for CPT 90683 (mRNA RSV vaccine mResvia) for patients 60+ years old. Update billing system to reflect $290.00 reimbursement rate. Providers should document patient age and high-risk conditions as outlined in ACIP guidelines. Submit any previously denied claims from June 26, 2024 forward for reprocessing.